Characterizing Hepatitis C Virus-Specific CD4<sup>+</sup> T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure.

Hartnell, Felicity; Esposito, Ilaria; Swadling, Leo; Brown, Anthony; Phetsouphanh, Chansavath; de Lara, Catherine; Gentile, Chiara; Turner, Bethany; Dorrell, Lucy; Capone, Stefania; Folgori, Antonella; Barnes, Eleanor; Klenerman, Paul

Characterizing Hepatitis C Virus-Specific CD4⁺ T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure.

Hartnell, Felicity; Esposito, Ilaria; Swadling, Leo; Brown, Anthony; Phetsouphanh, Chansavath; de Lara, Catherine; Gentile, Chiara; Turner, Bethany; Dorrell, Lucy; Capone, Stefania; Folgori, Antonella; Barnes, Eleanor; Klenerman, Paul.

Afiliación

Hartnell F; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Esposito I; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Swadling L; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Brown A; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Phetsouphanh C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
de Lara C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Gentile C; CEINGE-Advanced Biotechnologies, Naples, Italy.
Turner B; Jenner Vaccine Trials, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Dorrell L; Jenner Vaccine Trials, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Capone S; Reithera Srl, Rome, Italy.
Folgori A; Reithera Srl, Rome, Italy.
Barnes E; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Klenerman P; Jenner Vaccine Trials, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Hepatology ; 72(5): 1541-1555, 2020 11.

Article en En | MEDLINE | ID: mdl-32012325

Asunto(s)

Antivirales/uso terapéutico; Hepacivirus/inmunología; Hepatitis C Crónica/terapia; Linfocitos T Colaboradores-Inductores/inmunología; Vacunas contra Hepatitis Viral/administración & dosificación; Adenoviridae/genética; Línea Celular; Femenino; Vectores Genéticos/genética; Voluntarios Sanos; Hepacivirus/aislamiento & purificación; Hepatitis C Crónica/diagnóstico; Hepatitis C Crónica/inmunología; Hepatitis C Crónica/virología; Humanos; Inmunogenicidad Vacunal; Memoria Inmunológica; Masculino; Persona de Mediana Edad; Remisión Espontánea; Vacunas Sintéticas/administración & dosificación; Vacunas Sintéticas/genética; Vacunas Sintéticas/inmunología; Vacunas contra Hepatitis Viral/genética; Vacunas contra Hepatitis Viral/inmunología; Proteínas no Estructurales Virales/genética; Proteínas no Estructurales Virales/inmunología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Vacunas contra Hepatitis Viral / Linfocitos T Colaboradores-Inductores / Hepacivirus / Hepatitis C Crónica Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: En Revista: Hepatology Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google